Usa city Seattle covid-19 vaccine Usa city Seattle

COVID-19 Scan for Nov 24, 2021

Reading now: 700
www.cidrap.umn.edu

SARS-CoV-2 antibody levels predict COVID vaccine efficacy, study findsSARS-CoV-2 antibody concentrations predict COVID-19 vaccine effectiveness, with higher levels correlating with greater protection, according to an ongoing US phase 3 clinical trial yesterday in Science.A team led by researchers from Fred Hutchinson Cancer Research Center in Seattle evaluated 30,420 adult recipients of the Moderna mRNA COVID-19 vaccine at 99 centers for neutralizing and binding antibodies as correlates of risk for, and protection against, infection.They measured the antibodies at the second vaccine dose and then again 4 weeks later.

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA